XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Oct. 31, 2023
Cash flows from operating activities:      
Net earnings $ 2,529 $ 2,775 $ 3,263
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation, amortization and impairment 916 830 850
Stock-based compensation expense 522 452 438
Restructuring and other charges 405 301 527
Deferred taxes on earnings (6) (122) (923)
Other, net 116 (38) (10)
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (524) (929) 278
Inventory (828) (852) 668
Accounts payable 1,142 2,840 (1,240)
Net investment in leases related to integrated financing (131) (165) (110)
Taxes on earnings (391) (24) 198
Restructuring and other (326) (264) (310)
Other assets and liabilities 273 (1,055) (58)
Net cash provided by operating activities 3,697 3,749 3,571
Cash flows from investing activities:      
Investment in property, plant, equipment and purchased intangibles, net (897) (592) (593)
Purchases of available-for-sale securities and other investments (40) (4) (11)
Maturities and sales of available-for-sale securities and other investments 74 8 21
Collateral posted for derivative instruments (264) 0 0
Payments made in connection with business acquisitions, net of cash acquired (116) (58) (7)
Proceeds from business divestitures 66 0 0
Net cash used in investing activities (1,177) (646) (590)
Cash flows from financing activities:      
Payments of short-term borrowings with original maturities less than 90 days, net 0 0 (10)
Proceeds from debt, net of issuance costs 1,385 380 255
Payment of debt and other associated costs (1,387) (213) (1,700)
Stock-based award activities and others (126) (74) (99)
Repurchase of common stock (850) (2,100) (100)
Cash dividends paid (1,088) (1,075) (1,037)
Collateral returned for derivative instruments 0 0 (200)
Settlement of cash flow hedges 6    
Settlement of cash flow hedges   0 (3)
Net cash used in financing activities (2,060) (3,082) (2,894)
Increase in cash, cash equivalents and restricted cash 460 21 87
Cash, cash equivalents and restricted cash at beginning of period 3,253 3,232 3,145
Cash, cash equivalents and restricted cash at end of period (1) 3,713 3,253 3,232
Supplemental cash flow disclosures:      
Income taxes paid, net of refunds 535 649 398
Interest expense paid $ 437 $ 441 $ 548